Drugs / MSP3-LSP
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01341704 | May → Dec 2011 | Plasmodium falciparum malaria | Vac4All | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MSP3-LSP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01341704 ↗ |
| Modality | Vaccine | “MSP3-LSP experimental malaria vaccine” NCT01341704 ↗ |
| Route | Subcutaneous | “administered by subcutaneous route” NCT01341704 ↗ |